Study of MDX-010 in Subjects With Unresectable Stage III or Stage IV Malignant Melanoma

Clinical trial NCT00729950 · COMPLETED

Trial details

NCT number: NCT00729950
Sponsor: Bristol-Myers Squibb
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Malignant Melanoma

Start date: 2003-07-01
Primary completion: 2005-10-01
Enrollment: 92

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.